Surgery Partners, Inc. (SGRY)
SGRY Stock Price Chart
Explore Surgery Partners, Inc. interactive price chart. Choose custom timeframes to analyze SGRY price movements and trends.
SGRY Company Profile
Discover essential business fundamentals and corporate details for Surgery Partners, Inc. (SGRY) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Care Facilities
IPO Date
30 Sept 2015
Employees
15.00k
Website
https://www.surgerypartners.comCEO
J. Eric Evans
Description
Surgery Partners, Inc. operates a nationwide network of surgical facilities and associated medical services across the United States. Its business is categorized into two segments: Surgical Facility Services and Ancillary Services. These surgical venues include both ambulatory surgery centers and dedicated surgical hospitals, delivering non-urgent surgical procedures across various specialties such as gastroenterology, general surgery, ophthalmology, orthopedics, and pain management. The surgical hospitals additionally offer comprehensive ancillary services, including diagnostic imaging, pharmacy, laboratory, obstetrics, oncology, physical therapy, and wound care. The dedicated Ancillary Services segment further encompasses multi-specialty physician practices, urgent care facilities, and anesthesia services. By December 31, 2021, the company's portfolio consisted of 126 surgical facilities—specifically, 108 ambulatory surgical centers and 18 surgical hospitals—situated across 31 states. Founded in 2004, Surgery Partners, Inc. maintains its headquarters in Brentwood, Tennessee.
SGRY Financial Timeline
Browse a chronological timeline of Surgery Partners, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 4 Aug 2026
EPS estimate is $0.02, while revenue estimate is $830.03m.
Earnings released on 5 May 2026
EPS came in at -$0.03 surpassing the estimated -$0.15 by +80.00%, while revenue for the quarter reached $810.90m , beating expectations by +1.66%.
Earnings released on 2 Mar 2026
EPS came in at $0.12 falling short of the estimated $0.31 by -61.29%, while revenue for the quarter reached $885.00m , beating expectations by +2.10%.
Earnings released on 10 Nov 2025
EPS came in at $0.13 falling short of the estimated $0.19 by -31.58%, while revenue for the quarter reached $821.50m , missing expectations by -5.20%.
Earnings released on 5 Aug 2025
EPS came in at $0.17 surpassing the estimated $0.16 by +6.25%, while revenue for the quarter reached $826.20m , beating expectations by +0.32%.
Earnings released on 12 May 2025
EPS came in at $0.04 falling short of the estimated $0.08 by -50.00%, while revenue for the quarter reached $776.00m , missing expectations by -0.14%.
Earnings released on 3 Mar 2025
EPS came in at $0.44 surpassing the estimated $0.38 by +15.79%, while revenue for the quarter reached $864.40m , beating expectations by +8.04%.
Earnings released on 12 Nov 2024
EPS came in at $0.19 falling short of the estimated $0.25 by -24.00%, while revenue for the quarter reached $770.40m , missing expectations by -7.07%.
Earnings released on 6 Aug 2024
EPS came in at $0.21 matching the estimated $0.21, while revenue for the quarter reached $762.10m , beating expectations by +3.61%.
Earnings released on 7 May 2024
EPS came in at $0.10 surpassing the estimated $0.07 by +42.86%, while revenue for the quarter reached $717.40m , beating expectations by +2.77%.
Earnings released on 26 Feb 2024
EPS came in at $0.44 surpassing the estimated $0.37 by +18.92%, while revenue for the quarter reached $735.40m , missing expectations by -0.82%.
Earnings released on 7 Nov 2023
EPS came in at $0.19 surpassing the estimated $0.14 by +35.71%, while revenue for the quarter reached $674.10m , beating expectations by +0.27%.
Earnings released on 1 Aug 2023
EPS came in at $0.28 surpassing the estimated $0.07 by +300.00%, while revenue for the quarter reached $667.60m , missing expectations by -0.87%.
Earnings released on 1 May 2023
EPS came in at $0.08 surpassing the estimated $0.00 by +1.95k%, while revenue for the quarter reached $666.20m , beating expectations by +1.38%.
Earnings released on 1 Mar 2023
EPS came in at $0.27 surpassing the estimated $0.19 by +42.11%, while revenue for the quarter reached $707.10m , beating expectations by +2.77%.
Earnings released on 8 Nov 2022
EPS came in at -$0.02 falling short of the estimated -$0.01 by -143.90%, while revenue for the quarter reached $620.60m , missing expectations by -2.11%.
Earnings released on 2 Aug 2022
EPS came in at -$0.03 falling short of the estimated -$0.01 by -344.44%, while revenue for the quarter reached $615.40m , missing expectations by -1.36%.
Earnings released on 3 May 2022
EPS came in at -$0.09 falling short of the estimated -$0.05 by -80.00%, while revenue for the quarter reached $596.20m , beating expectations by +3.40%.
Earnings released on 28 Feb 2022
EPS came in at $0.23 falling short of the estimated $0.26 by -11.54%, while revenue for the quarter reached $610.20m , missing expectations by -2.27%.
Earnings released on 2 Nov 2021
EPS came in at -$0.05 falling short of the estimated -$0.03 by -52.11%, while revenue for the quarter reached $559.20m , beating expectations by +1.70%.
Earnings released on 4 Aug 2021
EPS came in at -$0.39 falling short of the estimated -$0.22 by -76.52%, while revenue for the quarter reached $543.30m , meeting expectations.
SGRY Stock Performance
Access detailed SGRY performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
